Provider of a drug discovery platform designed to broaden enablement of the efficient discovery of the next generation of breakthrough antibody drugs. The company's AlivaMab Mouse platform is an innovative, next-generation transgenic mouse platform, enabling biotechnology and pharmaceutical companies to efficiently discover and develop the next generation of human therapeutic antibodies to treat human diseases.
Most visits will take between 1.5 and 2 hours. The agenda for a specific visit depends on your group, its interests and objectives as well as on the host company. A visit may include a company or industry specific presentation, a discussion around a specific product or service, partnership opportunities, a demo, a meeting of the premises, etc.